Filters

Franck Bourdeaut, Edwige Kasper, Fadila Mihoubi-Bouvier, Aymeric Rouchaud, Tiphaine Adam de Beaumais, Brigitte Bressac, Philippe Denizeau, Gaëlle Bougeard, Thierry Leblanc, Geneviève Baujat, Caroline Michot, Nadège Corradini, Marion Gauthier-Villars, Camille Tlemsani, Laurence Brugières, Sarah Winter

Bulletin du cancer 2025;112(6):664-680

Full Text

Abstract

Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes.

M E Baser, S Sharif, R T Ramsden, J M Birch, D G R Evans

Journal of medical genetics 2006;43(4):289-94

Free Full Text

Abstract

Radiation-sensitive genetically susceptible pediatric sub-populations.

Ruth A Kleinerman

Pediatric radiology 2009;39 Suppl 1(Suppl 1):S27-31

Free Full Text

Abstract

Diagnosis of Li-Fraumeni Syndrome: Differentiating TP53 germline mutations from clonal hematopoiesis: Results of the observational AGO-TR1 trial.

Konstantin Weber-Lassalle, Philipp Harter, Jan Hauke, Corinna Ernst, Stefan Kommoss, Frederik Marmé, Nana Weber-Lassalle, Katharina Prieske, Dimo Dietrich, Julika Borde, Esther Pohl-Rescigno, Alexander Reuss, Beyhan Ataseven, Christoph Engel, Julia C Stingl, Rita K Schmutzler, Eric Hahnen

Human mutation 2019;39(12):2040-2046

Full Text

Abstract

The Impact of Li-Fraumeni and Germline Retinoblastoma Mutations on Leiomyosarcoma Initiation, Outcomes, and Genetic Testing Recommendations.

David H Abramson, Diana Mandelker, Robert G Maki, William D Tap, Cristina R Antonescu, Sujana Movva, Sarah Chiang, Martee L Hensley, Josephine K Dermawan

Clinical cancer research : an official journal of the American Association for Cancer Research 2024;30(20):4780-4790

Free Full Text

Abstract

Two metachronous tumors in the radiotherapy fields of a patient with Li-Fraumeni syndrome.

J P Bergerat, S Natarajan-Ame, T Frebourg, J M Limacher

International journal of cancer 2001;96(4):238-42

Full Text

Abstract

Assessing TP53 status in human tumours to evaluate clinical outcome.

C Béroud, T Soussi

Nature reviews. Cancer 2002;1(3):233-40

Full Text

Abstract

Results: 1 – 13 / 13

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Li-Fraumeni Syndrome""[mesh_terms]

Li-Fraumeni Syndrome: Narrative Review Through a Case Report with Ten Years of Primary Tumor Remission Associated with H387 07 Supplementation.

Hereditary cancer predisposition in children: genetic basis and clinical implications.

Sarcoma epidemiology and etiology: potential environmental and genetic factors.

A novel TP53 germline mutation in a family with a history of multiple malignancies: case report and review of the literature.

Genetics of childhood cancer.

R337H mutation of the TP53 gene as a clinical marker in cancer patients: a systematic review of literature.

Bone sarcomas and cancer predisposition syndromes.

Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes.

Radiation-sensitive genetically susceptible pediatric sub-populations.

Diagnosis of Li-Fraumeni Syndrome: Differentiating TP53 germline mutations from clonal hematopoiesis: Results of the observational AGO-TR1 trial.

The Impact of Li-Fraumeni and Germline Retinoblastoma Mutations on Leiomyosarcoma Initiation, Outcomes, and Genetic Testing Recommendations.

Two metachronous tumors in the radiotherapy fields of a patient with Li-Fraumeni syndrome.

Assessing TP53 status in human tumours to evaluate clinical outcome.

Results for
""Li-Fraumeni Syndrome""[mesh_terms]